- Lobbying
- Lobbying by GoodRx, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Thomas Rice | Legislative Director / Professional Staff Member Rep. Michael T. McCaul (TX-10) / House Foreign Affairs Committee Legislative Director / Professional Staff Member Rep. Michael T. McCaul (TX-10) / House Foreign Affairs Committee |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Q3 Report
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Executive Office of the President (EOP)
Office of Management & Budget (OMB)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Educate Members of Congress on issues related to data privacy. Monitor data privacy issues and legislation.
Educate Members of Congress on issues relating to drug pricing and health care costs, and monitor potential legislation that may affect drug costs on consumers.
Educate Members of Congress and Federal Officials on work on vaccine appointment scheduling tools.
Issues relating to the use of real-time benefit tools in healthcare..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate